6-Methyl-2-azaspiro[3.3]heptan-6-ol hydrochloride is primarily used in pharmaceutical research and development, particularly in the synthesis of novel drug compounds. Its unique spirocyclic structure makes it a valuable intermediate in the creation of bioactive molecules, often targeting the central nervous system. The compound is explored for its potential in developing treatments for neurological disorders, such as anxiety, depression, and cognitive impairments. Additionally, its structural features are utilized in medicinal chemistry to enhance the pharmacokinetic properties of drug candidates, improving their stability and bioavailability. Researchers also investigate its role in modulating specific receptors or enzymes, contributing to the discovery of new therapeutic agents.